SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC, Perrillo RP, Carey W, et al. Treatment of chronic hepatitis C with recombinant interferon alfa: a multicenter randomised, controlled trial. N Engl J Med 1989; 321:15011505.MEDLINE
  • 2
    Di Bisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, Goodman Z, et al. Recombinant interferon alfa therapy for chronic hepatitis C: a randomised doubled-blind, placebo-controlled trial. N Engl J Med 1989; 321:15061510.MEDLINE
  • 3
    Marcellin P, Boyer N, Giostra E, Degott C, Courouce AM, Degos F, Coppere H, et al. Recombinant human alpha-interferon in patients with chronic non-A, non-B hepatitis: a multicenter randomised controlled trial from France. Hepatology 1991; 13:393397.MEDLINE
  • 4
    Causse X, Godinot H, Chevallier M, Chossegros P, Zoulim F, Ouzan D, Heyraud JP, et al. Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis. Gastroenterology 1991; 101:497502.MEDLINE
  • 5
    Saracco G, Rosina F, Abate ML, Chaindussi L, Gallo V, Cerutti E, Di Napoli A. Long term follow-up of patients with chronic hepatitis C treated with different dose of interferon-alpha 2b. Hepatology 1993; 18:13001305.MEDLINE
  • 6
    Hoofnagle JH, Di Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997; 226:347356.
  • 7
    Toyoda H, Nakano S, Takeda I, Kumada T, Sugiyama K, Osada T, Kiriyama S, et al. Retreatment of chronic hepatitis C with interferon. Am J Gastroenterol 1994; 89:14531457.MEDLINE
  • 8
    Gerken G, Teuber G, Goergen B, Meyer zum Buschenfelde KH. Interferon-alpha retreatment in chronic hepatitis C. J Hepatol 1995; 22:118121.MEDLINE
  • 9
    Kakumu S, Yoshioka K. Retreatment with interferon in patients with chronic hepatitis C [Letter] J Hepatol 1994; 21:483.MEDLINE
  • 10
    Marriott E, Quiroga JA, Carreno V. Retreatment of chronic hepatitis C with interferon-alpha. J Infect Dis 1992; 166:12001001.MEDLINE
  • 11
    Camps J, Garcia N, Riezu-Boj JI, Civeira MP, Prieto J. Ribavirin in the treatment of chronic hepatitis C unresponsive to alfa interferon. J Hepatol 1993; 19:408412.MEDLINE
  • 12
    Koskinas J, Tibbs C, Saleh MG, Pereira LMMB, McFarlane IG, Williams R. Effects of ribavirin on intrahepatic and extrahepatic expression of hepatitis C virus in interferon nonresponsive patients. J Med Virol 1995; 45:2934.MEDLINE
  • 13
    Brillanti S, Garson J, Foli M, Whitby K, Deaville R, Masci C, Miglioli M, et al. A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C. Gastroenterology 1994; 107:812817.MEDLINE
  • 14
    Schvarcz R, Yun ZB, Sonnerborg A, Weiland O. Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone. J Med Virol 1995; 46:4347.MEDLINE
  • 15
    Kugelmas M, Lieberman BY, Carey WD. Deironisation in chronic hepatitis C patients previously non-responsive to interferon improves transaminases but not viral activity [Abstract] Gastroenterology 1995; 108:A1004.
  • 16
    Bacon BR, Rebholz AE, Fried M, Di Bisceglie AM. Beneficial effects of iron reduction therapy in patients with chronic hepatitis C who failed to respond to interferon [Abstract] Hepatology 1993; 18:150A.
  • 17
    Martinot-Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N, Poliquin M, Degott C, et al. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology 1995; 22:10501056.MEDLINE
  • 18
    Marcellin P, Boyer N, Pouteau M, Benhamou JP, Erlinger S. Retreatment with interferon-alpha of chronic hepatitis C. Lancet 1994; 344:690691.MEDLINE
  • 19
    Alberti A, Chemello L, Noventa F, Cavalletto L, De Salvo G. Therapy of hepatitis C: re-treatment with alpha interferon. Suppl. 1 Hepatology 1997; 26:137S142S.MEDLINE
  • 20
    Keeffe EB, Holllinger FB. Therapy of hepatitis C: consensus interferon trials. the Consensus Interferon Study Group. Suppl. 1 Hepatology 1997; 16:101S107S.
  • 21
    Payen JL, Izopet J, Galindo V, Zarski JP, Seigneurin JM, Dussais E, Langlois C, et al. A comparison of three interferon alfa-2b regimens for retreatment (RTT) of patients with chronic hepatitis C with prior complete response followed by relapse: a controlled, randomized trial [Abstract] Suppl. Hepatology 1996; 24:273A.
  • 22
    Van Thiel DH, Friedlander L, Malloy P, Fagiuoli S, Wright HI, Gasbarrini A, Caraceni P. Retreatment of hepatitis C interferon non-responders with larger doses of interferon with and without phlebotomy [Abstract] Gastroenterology 1994; 106:A1002.
  • 23
    Okanoue T, Sakamoto S, Itoh Y, Minami M, Yasui K, Sakamoto M, Nishioji K, et al. Side effects of high-dose interferon therapy for chronic hepatitis C. J Hepatol 1996; 25:283291.MEDLINE
  • 24
    Miella M, Antonelli G, Santantonio T, Giannelli G, Currenti M, Monno L, Turriziani O, et al. Treatment with natural IFN of hepatitis C patients with or without antibodies to recombinant IFN. Hepatol Gastroenterol 1995; 42:201204.
  • 25
    Hagiwara H, Hayashi N, Oshita M, Katayama K, Kasahara A, Fusamoto H, Kamada T. Retreatment with 24-week course of interferon-alpha for patients with chronic hepatitis C. Int Hepatol Commun 1996; 5:135142.
  • 26
    Davis GL, Esteban-Mur R, Rustgi V, Hoefs J, Gordon S, Trépo C, Shiffman M, et al. Retreatment of relapse after interferon therapy for chronic hepatitis C: an international randomized controlled trial of interferon plus ribavirin vs interferon alone [Abstract] Suppl. Hepatology 1997; 26(Suppl:247A.
  • 27
    Horiike N, Kurose K, Ohkura I, Masumoto T, Nakanishi K, Michitaka K, Onji M. Retreatment with interferon in chronic hepatitis C [Abstract] J Hepatol 1994; 21:1155.MEDLINE